The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development

Area of Science:

• Bone Biology
• Vascular Biology
• Cellular Signaling

Background:

• Skeletal development and bone turnover are closely linked with angiogenesis.
• Osteoblasts can sense oxygen levels and activate the hypoxia-inducible factor alpha (HIF alpha) pathway in response to hypoxia.
• The HIF alpha pathway's role in coordinating bone and vascular development requires further elucidation.

Purpose of the Study:

• To investigate the role of HIF alpha in osteoblasts in regulating angiogenesis and osteogenesis.
• To determine the impact of manipulating HIF alpha levels on bone density and vascularization.

Main Methods:

• Utilized genetically modified mice with selective deletion of the von Hippel-Lindau (Vhl) gene to overexpress HIF alpha in osteoblasts.
• Generated mice lacking Hif1a in osteoblasts.
• Assessed skeletal phenotypes, including bone density and vascularization, in mutant mice.
• Performed in vitro studies on embryonic metatarsals to evaluate endothelial sprouting.

Main Results:

• Overexpression of HIF alpha in osteoblasts (Vhl mutants) led to increased Vegf levels, resulting in significantly denser and more vascularized long bones.
• Loss of Hif1a in osteoblasts caused thinner, less vascularized long bones compared to controls.
• Loss of Vhl in osteoblasts enhanced endothelial sprouting in vitro, but had minimal impact on osteoblast function without blood vessels.
• Mice lacking both Vhl and Hif1a exhibited an intermediate bone phenotype, suggesting overlapping HIF functions.

Conclusions:

• Activation of the HIF alpha pathway in osteoblasts promotes both angiogenesis and osteogenesis.
• HIF alpha elevates VEGF levels, driving increased bone modeling and vascularization.
• These findings highlight the critical role of HIF alpha in coordinating vascular and skeletal development through cell-nonautonomous mechanisms.